Share

Videos

Allergan Rejects $46B Bid by Valeant Pharmaceuticals

The Wall Street Journal
|
May 12, 2014 AT 9:17 AM
Victor Reklaitis takes a look at the markets, including three stocks to watch today. Photo: Getty.